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Summary. We re port on the progression of myopathol-
ogy by comparing two biopsies from a patient with a 
Kearns-Sayre-Syndrome. The first biopsy was taken in 
1979 and showed 10 % ragged-red fibers. Myopathic 
changes were slight including internal nuclei and fiber 
splitting in 10 % of the fibers. Electron microscopy 
revealed typical mitochondrial abnormalities with 
regard to number and shape. In 1989 a second biopsy 
was performed for an extended analysis of mitochon-
drial DNA. This time less than 5 % of all fibers were 
ragged-red. Severe myopathic changes could be 
detected whieh so far has rarely been reported in 
mitoehondrial cytopathy. 
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The morphological hallmarks for the diagnosis of mito-
ehondrial myopathies are the so called "ragged-red" 
fibers and ultrastructural changes of mitoehondria sueh 
as a proliferation and coneentric arrangement of cristae, 
and paraerystalline inclusions [3]. Myopathie features 
such as an increased variability of fiber size, fiber 
atrophy, fiber type predominance or deficiency, internal 
nuclei, and motheaten fibers are usually slight [4]. 
We report here a progression of muscle pathology in a 
53-year-old male patient with Kearns-Sayre syndrome 
and partial cytochroma c oxidase deficieney, who showed 
a marked increase of muscle degeneration after a 
lO-year follow-up. Clinically this period was character-
ized by a more rapid decline of muscle strength and the 
development of new symptoms. 
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Case report 
In 1979 a 53-year-old patient presented with bilateral ptosis, which 
had developed 6 months previously, and a mild generalized muscle 
weakness and exercise intolerance since early childhood. The 
disease was only slowly progressive until the age oi 40, followed by 
a more rapidly increasing weakness of proximal limb muscles. 
There was no past medical history and no family history oi 
neuromuscular diseases. In 1979 neurological examination 
revealed bilateral ptosis, slight external ophthalmoplegia, facial 
weakness, and BMRC grade 4 weakness of neck, trunk, and 
proximallimb muscles. 
During the lO-year follow-up he developed exercise dyspnea, 
intermittent tachycardia, diabetes mellitus, and mild slowly pro-
gressive ataxia. Muscle strength had declined to grade 3/4. Besides 
an initially raised creatine phosphokinase level to 191 VII (nor-
mal< 80 V/I) all routine laboratory examinations revealed normal 
values. Serum lactate under resting conditions was normal, 
whereas in CSF lactate was raised to 2.8 mmol/I (nor-
mal< 2.1 mmollI). CSF total protein was not elevated. Fundosco-
py showed pigmentary degeneration of the retina. Because of 
intermittent tachycardia and exercise dyspnea an extensive cardio-
logical examination was performed. Rest, exercise, and long-term 
ECG as weil as echocardiography and coronary arteriography 
showed no abnormalities. The electron microscopic examination of 
a heart muscJe biopsy showed abnormal mitochondria with 
concentric cristae. Initially EMG showed a pure myopathie and 
later on a mixed myopathie and neurogenic pattern. In 1989 the 
initially normal nerve conduetion velo city of the right tibial nerve 
was reduced to 39 m/s. 
Biopsy findings 
The histological, histochemical, electron mi croscopic , and bio-
chemieal methods are described elsewhere [2, 5]. A first muscle 
biopsy (right biceps brachii) was performed in 1979 and confirmed 
the clinically suspected diagnosis of mitoehondrial myopathy. The 
modiiied Gomori tri chrome stain (Fig. la) showed 10 % ragged-
red fibers. Some of the fibers were conspicuous for extensive 
vaculolation. 
Myopathic changes were only slight and consisted oi a mild 
focal proliferation oi endomysium, central nudei in 10 % of the 
fibers and fiber splittings. In addition, H&E stains disclosed a few 
regenerating fibers (not shown). Morphometric analysis of 200 
fibers of each type revealed mild atrophy of type 1 fibers (atrophy 
factor 470; Fig. 2) and mild hypertrophy of type 2 fibers (hyper-
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Fig. 1. In 1979 fibers with the typical ragged-red appearance and 
vacuolar inclusions were present (a; arrowheads); 10 years later 
mitochondrial proliferation was conspicuous only in atrophie fibers 
(b, arrowhead). Furthermore, a marked variability of fiber size 
diameter is present. Modified Gomori trichrome, x 140 
trophy factor 750). Atrophy and hypertrophy factors were calcu-
lated by a computerized system following the criteria of Dubowitz 
and Brooke [1]. Electron microscopie examinations revealed 
abnormal mitochondria with a variety of structural alterations, 
such as enlarged mitochondria with concentric lamellated cristae 
and paracrystalline inclusions (Fig. 3a). 
Pathological changes in type 1 fibres 
Fig. 3. Electron microscopy revealing abnormal mitochondria 
with paracrystalline inclusions and hypertrophie concentrie lamel-
lae in 1979 (a). In 1989 structural abnormalities in mitochondria are 
less marked (b). a x 23 000; b x 45 000 
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Fig. 2. Morphometric analysis of atrophy 
and hypertrophy factors in type 1 fibers. 
Analysis of the second biopsy reveals marked 
progression of atrophy and strong hypertro-
phy 
In 1989 a second biopsy (right rectus femoris) was performed 
for biochemical reasons and for analysis of the mitochondrial 
genome. The informed consent of the patient was obtained. Again 
the modified Gomori (Fig. 1b) showed aggregation of mitochon-
dria, but only in less than 5 % of the fibers. Vacuolation of fibers 
could no longer be seen. By electron microscopy abnormal 
mitochondria with concentric lamellated or rarified cristae were 
only visible in atrophie fibers (Fig. 3b). Paracrystalline inc1usions 
were now absent. Furtherrnore, moderate to severe myopathic 
changes could be seen. They consisted of small groups of fat cells, 
some acute fiber necroses, internal nuc1ei in about 20 % of fibers 
and pyknotic nuc1ear c1umps. There was a highly increased 
variation of fiber size, which was especially pronounced in type 1 
fibers (Fig. 2): atrophyand hypertrophy factors were now 1410 and 
1455, respectively. Type 2 fibers also underwent strong atrophy 
(atrophy factor 1180) but only medium-grade hypertrophy (hyper-
trophy factor 1020). Secondary alterations of musc1e fiber mem-
brane composition were exc1uded by normal dystrophin (Fig. 4) 
and spectrin immunocytochemistry (not shown). 
Histochemieal stainings revea1ed a partial cytochrome c oxi-
dase deficiency in about 80 % of fibers, which could be confirmed 
by biochemical examinations. The cytochrome c oxidase value was 
1.6 U/g musc1e (normal: 1.73-5.0 U/g musc1e). Non-collagen 
musc1e protein was normal. 
Analyses of the mitochondrial genome were performed on the 
1989 biopsy using the Southern blot technique. In addition to the 
16.5-kb band only faint bands could be detected, indieating 
multiple deletions of mitochondrial DNA (data not shown). 
Fig. 4. Immuncytochemical detection of the C terminus of dystro-
phin shows normal continuous labeling of plasma mem-
branes. x 140 
Fig. 5. Cytochrome c oxidase staining shows that about 80 % of 
the fibers are negative, some fibers have partial deficiency 
(arrowhead). x 140 
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Discussion 
With an age of onset befare 20 years, progressive 
external ophthalmoplegia, pigmentary retinopathy and 
ataxia, our patient fulfilled the eriteria of Kearns-Sayre 
syndrome [1]. After a disease duration of about 45 years 
muscle pathology showed, in addition to the typieal 
mitoehondrial abnormalities, marked myopathie 
ehanges. In the literature only a few reports exist about 
severe myopathie abnormalities in mitoehondrial myop-
athy [1, 4]. In contrast to our ease all of these patients 
were children below the age of 12 years. Regardless this 
significant age differenee all patients had a fatal or at 
least severely disabling course of disease. 
In comparison to the first 35 years of the disease our 
patient noticed a more rapid clinical decline during the 
last 10 years. Morphologically this progression coin-
cided with an outstanding increase of myopathie muscle 
degeneration and a decrease of mitochondrial abnor-
malities. The number of ragged-red fibers had fallen 
from 10 % to less than 5 %, and ultrastructural changes 
of mitochondria became rare. Although the second 
biopsy had been taken from a different muscle, the 
influence of the biopsy site is probably of minar 
importance as clinical affliction of both muscles was 
comparable in 1989. Furthermore, pathologieal altera-
tions affected both fiber types, thus reducing a possible 
bias by a different fiber-type composition of these 
muscles. 
One could speculate that the labile energy status of 
the mitoehondria in ragged-red fibers led to high-grade 
atrophy or neerosis of these fibers with subsequent 
replaeement by eonneetive tissue and fat. Thus, only 
fibers whose mitochondria exhibited minor alternations 
survived. 
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